Home > Income Statement > AARTI DRUGS

AARTI DRUGS
Revenue

    Back to Income Statement
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹2,716 Cr₹2,489 Cr₹2,155 Cr₹1,806 Cr₹1,561 Cr

What is the latest Revenue of AARTI DRUGS ?

The latest Revenue ratio of AARTI DRUGS is ₹2,716 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹2,716 Cr
Mar2023₹2,489 Cr
Mar2022₹2,155 Cr
Mar2021₹1,806 Cr
Mar2020₹1,561 Cr

How is Revenue of AARTI DRUGS Trending?

Years Revenue % Change
Mar2024 ₹2,716 Cr
9.14
Mar2023 ₹2,489 Cr
15.49
Mar2022 ₹2,155 Cr
19.31
Mar2021 ₹1,806 Cr
15.71
Mar2020 ₹1,561 Cr -

Compare Revenue of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,839.8 Cr 11% 14.7% -11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹414,533.0 Cr 3.6% 2.5% 6.2% Stock Analytics
DIVIS LABORATORIES ₹180,215.0 Cr -2.9% 1.5% 48.1% Stock Analytics
CIPLA ₹120,428.0 Cr -0.1% -2.4% -1.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹116,410.0 Cr 2.5% 4.9% 15.2% Stock Analytics
DR REDDYS LABORATORIES ₹105,253.0 Cr -0.7% -6.4% -5.2% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

11%

14.7%

-11%

SENSEX

-1.4%

1.8%

3.3%


You may also like the below Video Courses